Poster entitled “Clinical Pharmacokinetics and Tolerability of a Novel Oral GABAA Receptor Positive Allosteric Modulating Candidate for Epilepsy” (Form 8-K)

Lipocine Inc. published this content on December 11, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 11, 2025 at 22:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]